HuGE Literature Finder
Records
1
-
14
| A multiethnic bidirectional Mendelian randomization study negates causal effects of C-reactive protein concentrations on lung cancer. Translational lung cancer research 2021 Dec 10 (12): 4380-4389. Wu Xiang-Rong, Peng Hao-Xin, Xiong Shan, Wen Yao-Kai, Chen Jia-Na, Li Cai-Chen, Jiang Yu, Su Zi-Xuan, Liu Jun, He Jian-Xing, Liang Wen-Hua, Cai Xiu- |
| Development of RECLS score to predict survival in lung cancer patients with malignant pleural effusion. Translational lung cancer research 2021 Mar 10 (3): 1318-1326. Zhang Tianli, Chen Xi, Wan Bing, Xu Yangyang, Liu Hongbing, Lv Tangfeng, Zhan Ping, Song Yo |
| High serum C-reactive protein levels predict survival in patients with treated advanced lung adenocarcinoma. Journal of thoracic disease 2021 Mar 13 (3): 1476-1484. Hotta Takamasa, Nakashima Kazuhisa, Hata Kojiro, Tsubata Yukari, Isobe Takes |
| C-reactive protein gene 1846C>T polymorphism is associated with increased risk and clinical features of lung cancer: a case-control study. Bioscience reports 2019 May . Chen Chen, Liu Jing-Ni, Zhao Jian-Qiang, Zang B |
| Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients. Psycho-oncology 2019 Apr . McFarland Daniel C, Jutagir Devika R, Rosenfeld Barry, Pirl William, Miller Andrew H, Breitbart William, Nelson Christi |
| Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC cancer 2018 Jul 18 (1): 739. Berg Janna, Halvorsen Ann Rita, Bengtson May-Bente, Taskén Kristin A, Mælandsmo Gunhild M, Yndestad Arne, Halvorsen Bente, Brustugun Odd Terje, Aukrust Pål, Ueland Thor, Helland Åsla |
| Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study. Journal of thoracic disease 2017 Dec 9 (12): 5068-5074. Shen Qian, Dong Xiaoqi, Tang Xiaoping, Zhou Jianyi |
| Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population. International journal of cancer. Journal international du cancer 2015 Dec 137 (11): 2696-704. Kjaergaard Alisa D, Nordestgaard Børge G, Johansen Julia S, Bojesen Stig |
| Polymorphisms in C-reactive protein and Glypican-5 are associated with lung cancer risk and Gartrokine-1 influences Cisplatin-based chemotherapy response in a Chinese Han population. Disease markers 2015 2015 824304. Zhang Shuo, Thakur Asmitananda, Liang Yiqian, Wang Ting, Gao Lei, Yang Tian, Li Yang, Geng Tingting, Jin Tianbo, Chen Tianjun, Liu Johnson J, Chen Mingw |
| Evaluation of the potential for lymph node metastasis using CRP 1846C>T genetic polymorphism in invasive breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5931-5. Terata Kaori, Motoyama Satoru, Kamata Shuichi, Hinai Yudai, Miura Masatomo, Sato Yusuke, Yoshino Kei, Ito Aki, Imai Kazuhiro, Saito Hajime, Minamiya Yoshihi |
| Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan. Cytokine 2014 Jan 65 (1): 88-94. Kiyohara Chikako, Horiuchi Takahiko, Takayama Koichi, Nakanishi Yoic |
| C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. European journal of cancer (Oxford, England : 1990) 2011 Feb 47 (3): 404-12. Heikkilä Katriina, Silander Kaisa, Salomaa Veikko, Jousilahti Pekka, Koskinen Seppo, Pukkala Eero, Perola Mark |
| The CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010 Dec 31 (6): 673-9. Minamiya Yoshihiro, Miura Masatomo, Hinai Yudai, Saito Hajime, Ito Manabu, Imai Kazuhiro, Ono Takashi, Motoyama Satoru, Ogawa Jun-ic |
| C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Nov 24 (33): 5216-22. Siemes Claire, Visser Loes E, Coebergh Jan-Willem W, Splinter Ted A W, Witteman Jacqueline C M, Uitterlinden André G, Hofman Albert, Pols Huibert A P, Stricker Bruno H |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 06, 2022
- Content source: